Castleview Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
BTW
Castleview Partners's ACLS Position: Q1 2025 in Review
Castleview Partners sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 230 shares — an estimated $16.1K sold.
Castleview Partners first reported a position in ACLS in Q3 2023 and held it in 6 quarters. The position peaked at $32.7K in Q2 2024. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.
- Castleview Partners reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
- Castleview Partners sold 230 Axcelis shares in Q1 2025, an estimated $16.1K.
- Castleview Partners first reported a position in Axcelis in Q3 2023 and held it in 6 quarters.
- Castleview Partners's Axcelis position peaked at $32.7K in Q2 2024.
- 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.
Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.